Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02925195 · ClinicalTrials.gov registry record · NA
Individualized Response to Vitamin D Treatment Study
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 666
- Enrollment target
NCT02925195 is a NA study that has completed, run by University of Washington. The registered enrollment target is 666 participants.
The verdict
NCT02925195, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 666 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine individual-level genetic and metabolic characteristics that modify the response to cholecalciferol treatment. This study is double blind, parallel design, randomized clinical trial that will assess genetic and metabolic characteristics that modify the response to cholecalciferol treatment. . Eligible participants will be randomly assigned to receive cholecalciferol treatment (2,000 international units of cholecalciferol daily by mouth) or placebo in a 3:1 ratio for a total duration of 16-weeks. The planned sample size is 1,600. The primary aim of this study is to identify genetic polymorphisms, clinical characteristics, and biomarkers that modify the biologic response to vitamin D3 treatment, assessed by changes in serum concentrations of parathyroid hormone (PTH) and 1,25(OH)2D and urine calcium excretion.
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 666 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2022-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02925195
The ClinicalTrials.gov registry entry for NCT02925195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 666 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02925195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02925195 about?
NCT02925195 is a clinical study titled "Individualized Response to Vitamin D Treatment Study". The goal of this clinical trial is to determine individual-level genetic and metabolic characteristics that modify the response to cholecalciferol treatment. This study is double blind, parallel design, randomized clinical trial that will assess genetic and metabolic characteristics that modify the...
What is the current status of trial NCT02925195?
This trial is currently completed. It is a NA study. The enrollment target is 666 participants. The study started on 2017-01-11. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT02925195?
The interventions under investigation include: Placebo (DRUG), Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02925195?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.